Clinical trials
2 active studies led by Cutiss AG, of 4 in all
Source: ClinicalTrials.gov, Studies with Cutiss AG (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 3Markets in public records
- 0Regions & countries
- 2Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Cutiss AG or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Cutiss AG
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Cutiss AG leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Cutiss AG or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Cutiss AG: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Cutiss AG is in.
From our blog
Stories on the topics Cutiss AG works in.
Collagen Supplements: Skin, Joints and Real Evidence
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read
Dermatology Diagnostics: AI and Skin Health
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read
Ambulance Services: The First Link in Emergency Care
More than half of deaths in low- and middle-income countries come from conditions emergency care could treat…
Read